Monday, September 25, 2017
NantKwest Names New Board Director
Culver City-based immunotherapy developer NantKwest, one of the companies run by biotech billionaire Patrick Soon-Shiong, says that it has named Fred Driscoll, the former Chief Financial Officer of Flexion Therapeutics, to its board. According to NantKwest, Driscoll is taking the position that is being vacated by Richard Kusserow. Kusserow served as CFO of Flexion Therapeutics from 2013 until earlier this year, when he retired, and also served at Novavax, Genelabs, Astraris, OXiGENE, and Collagenesis Corporation.